Acute Limb Ischemia: Surgical and Endovascular Treatment


Acute limb ischemia (ALI) is an emergent vascular condition, wherein a rapid decrease in lower extremity arterial perfusion threatens limb viability. Despite advances in the prompt diagnosis and surgical management of limb ischemia, the reported rates of limb loss with amputation approach 15% of hospitalized patients, with a 15%–20% mortality rate within one year of diagnosis. , The etiologies of ALI, initial clinical evaluation, and medical decision-making are reviewed at length in previous chapters. This chapter presents the open surgical and endovascular therapeutic options in management of acute limb ischemia, with a therapeutic algorithm provided to assist treatment selection.

Initial Management

After establishing the diagnosis and classifying the severity of ischemic insult, several perioperative measures critical to patient outcomes are enacted. Systemic anticoagulation should be initiated immediately upon confirmation of ALI and considered earlier in the diagnostic work-up if a high clinical suspicion of limb ischemia exists. Subset analysis of a randomized trial examining use of antiplatelet agents in peripheral arterial disease illustrated several clinical risk factors associated with ALI. The study noted previous revascularization ( P <0.01), baseline atrial fibrillation ( P = 0.03), and baseline ankle–brachial index lower than 0.6 ( P <0.01) as clinical factors associated with higher risk of ALI. Anticoagulation maintains patency to distal vascular beds and helps reduce the risk of further arterial thromboembolic occlusion. An initial weight-based bolus of unfractionated heparin 70–100 units/kg is followed by a continuous intravenous infusion of 1000 units/h. If an emergent intervention is not planned, heparin dosing should be titrated with bolus as required to maintain either an activated partial thromboplastin time (aPTT) at two to three times above normal range or an anti-factor Xa level in therapeutic range. For patients with known heparin allergy, a direct thrombin inhibitor can be substituted as systemic anticoagulant with established protocols for both perioperative and intraoperative use.

Perioperative lab evaluation should include complete blood count, coagulation studies, basic or complete metabolic panel, baseline serum fibrinogen for patients with arterial thrombolysis as part of the treatment strategy, blood type and cross-matching. In patients with recurrent thromboembolic events or idiopathic arterial occlusion, a full hypercoagulability workup is warranted. Arterial blood gas for measurement of acid–base balance and a baseline creatine phosphokinase (CPK) level to monitor ischemic-reperfusion injury are also valuable adjuncts. Ongoing fluid resuscitation is key to mitigating secondary systemic organ insults as revascularization for ALI is associated with intravascular volume depletion following the inflammatory response of ischemia–reperfusion injury, as well as myoglobinuria and contrast-induced acute kidney injury.

Treatment Selection

Therapeutic Algorithm

The acuity of symptom onset and clinical manifestation of limb ischemia guides treatment strategies. Reporting standards for ALI exist to guide timing and choice of intervention (see Table 103.1). The reported success of open and endovascular therapies for each level of acute ischemia also allows for creation of a therapeutic algorithm (see Chapter Algorithm , below for guidance).

Class I ischemia is a viable limb, wherein the arterial occlusion has not compromised sensorimotor function and distal perfusion is maintained via collateral pathways. As the limb is not immediately threatened a window of time does exist to allow for completion of diagnostic studies, medical optimization of comorbidities and appropriate risk stratification. If revascularization is elected, patient and anatomic candidacy for an endovascular-first approach should be assessed. Viable tissue beds are more likely to tolerate the delayed time to reperfusion inherent to endovascular therapies in this minimally ischemic class.

The category of class II ischemia represents threatened limbs, mandating timely revascularization for limb salvage. The class is subdivided into marginally (IIa) and immediately (IIb) threatened limbs based on severity of ischemic neurologic deficits, with prompt and accurate characterization key to guiding revascularization. In the marginally threatened limb (IIa), a less severe ischemic insult allows for greater consideration of an endovascular-first approach. Etiology of arterial occlusion, patient comorbidities, presence of an arterial bypass graft or intraluminal stent, physician competency with endovascular therapies, and emergent availability of operative suites and vascular surgeons for failed endovascular intervention should all be considered in decision making. With progression in extent of sensory and motor neurologic deficits, ALI is classified as immediately threatened (IIb) and requires emergent revascularization. At this level of ischemia salvage of neurologically intact viable tissue is time-sensitive, favoring traditional open revascularization. An endovascular approach with more rapid means of revascularization, including aspiration or pharmacomechanical thrombectomy devices, may be considered for the skilled operator. An endovascular-first attempt for class IIb ALI is best suited for a vascular surgeon with proficiency in open and endovascular techniques, performed in an operative hybrid suite where advanced diagnostic imaging and ability to immediately transition to an open revascularization increases technical success of the limb-salvage intervention.

In the most severe class of ALI (III), primary limb amputation should be elected as definitive therapy. The profound extent or duration of limb ischemia results in irreversible damage to nerve sensory and motor function, and muscle rigor with limb paralysis. Revascularization in this class is most often unsuccessful in salvaging a neurologically functional limb, with the risks of systemic insults and morbidity after attempted revascularization far exceeding potential benefits.

Surgical Revascularization

Surgical revascularization remains an effective strategy for management of limb ischemia, regardless of ischemic class. Vascular surgeons should develop and maintain advanced skills in the open surgical techniques as they can be utilized as primary therapy for ALI, in salvage-type settings when endovascular therapy has failed or been incomplete, or in hybrid interventions with planned or staged open and endovascular segments.

Operative Techniques

Surgical revascularization for limb ischemia may include one or more of the following: (1) catheter embolectomy or thrombectomy; (2) arterial bypass procedures; (3) arterial thromboendarterectomy; (4) hybrid vascular procedures with open and endovascular components.

Catheter Embolectomy or Thrombectomy

First reported nearly six decades ago, the Fogarty embolectomy catheter (Edwards Lifesciences; Irvine, CA) has been the de facto gold standard for surgical extraction of acute and chronic thromboembolic disease. , Fogarty catheters are available in a variety of usable lengths, catheter French (F) size, inflated balloon diameters, with options designed for over-the-wire, arterial, venous, and bypass graft thrombectomy use. Vascular arterial exposure and basics of surgical technique are covered in previous chapters. The site of surgical cutdown for arterial exposure is dependent on the anatomic location of obstruction. An iliac or femoral arterial obstruction may be best approached via exposure at the common femoral level, while patients with distal bypass graft or concomitant popliteal–tibial level thrombosis may also require exposure at the most distal extent of arterial blockage. Following arterial exposure with control of inflow and outflow branches, therapeutic anticoagulation is confirmed, and vascular occlusion performed. An arteriotomy is made either transverse just proximal to branch points, or longitudinal if needed for endarterectomy or bypass graft anastomotic revision. Balloon thrombectomy catheters are sequentially passed proximally and then into distal branches with standard technique until no visible thrombus is removed, and both pulsatile inflow and distal back-bleeding are restored. On-table angiogram should be performed to confirm patency of treated vessels. Figure 104.1 shows the completion angiogram in a patient treated with catheter thrombectomy for acute limb ischemia. The patient had undergone emergent bedside percutaneous placement of cannula for extra-corporeal membrane oxygenation (ECMO) one day prior to operative exploration and had developed clinical signs of ALI within 24-hours post-procedure. Operative exploration revealed cannulation at the proximal superficial femoral artery (SFA) with focal dissection of calcific plaque at the level of the femoral bifurcation, and extensive acute thrombotic occlusion of SFA and above-knee popliteal artery. Revascularization required femoral exploration, femoral–popliteal antegrade balloon thrombectomy, focal femoral bifurcation endarterectomy with bovine pericardial patch angioplasty. Repair resulted in restoration of in-line arterial flow and palpable pedal level pulses, with angiogram confirming patency of vessels without residual thrombus.

Figure 104.1, Preoperative CTA ( A ) demonstrating thrombosis of left superficial femoral artery (SFA) and popliteal artery ( yellow arrows ). Post-thrombectomy angiogram ( B–D ) showing patency from femoral to popliteal bifurcations.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here